Company
Vor Biopharma
- Headquarters:
- Boston, MA
Description
Develops telitacicept, a BAFF/APRIL inhibitor for autoimmune diseases, aiming to rebalance immunity by blocking survival signals for harmful immune cells.
Related
Merck Cambridge Discovery ($MRK)Develops medicines and vaccines through research, clinical trials, and publications, focusing on diseases including cancer, infectious,…
Cartesian Therapeutics ($RNAC)Develops clinical-stage mRNA cell therapies designed to treat autoimmune diseases, aiming to expand access to cell therapy for patients…
SilmarilSecures AI agent inference calls by blocking harmful outcomes at runtime for applications exposed to prompt injection, unauthorized tool…
Artiva Biotherapeutics ($ARTV)Develops off-the-shelf, non-genetically modified natural killer cell therapies for deep B-cell depletion, aiming to help patients with…
Kyverna Therapeutics (San Diego)Develops cell therapies for autoimmune disease patients, including an autologous CD19-targeting CAR T candidate being studied in ongoing…
Leibniz-Institut für Immuntherapie (LIT)The institute develops immune cell therapies for cancer, autoimmune disease, and chronic inflammation, spanning discovery research,…
Ditto BiosciencesDiscovers drug candidates by using parasite biology and AI to identify parasite proteins that could treat autoimmune diseases driven by an…
Cabaletta Bio ($CABA)Develops engineered T cell therapies for autoimmune diseases, including rese-cel in Phase 1/2 trials for lupus, myositis, systemic…
Sana Biotechnology ($SANA)Builds engineered cell medicines that repair or control genes, or replace damaged cells, for patients with diseases including diabetes,…
Karyopharm Therapeutics ($KPTI)Develops and investigates oral nuclear export inhibitor cancer therapies for patients with cancer, especially in disease areas with high…
Mercury Systems ($MRCY)Mercury Systems builds secure mission-critical aerospace and defense technologies, including signal and data processing and compact RF…
Kanvas BiosciencesBuilds microbiome drug discovery and spatial mapping technology to image host-microbiome interactions and develop clinical-stage therapies…